Literature DB >> 16681839

Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system.

Luz P Blanco1, Victor J DiRita.   

Abstract

To elucidate mechanisms involved in M cell uptake and transcytosis of Vibrio cholerae, we used an in vitro model of human M-like cells in a Caco-2 monolayer. Interspersed among the epithelial monolayer of Caco-2 cells we detect cells that display M-like features with or without prior lymphocyte treatment and we have established key parameters for V. cholerae transcytosis in this model. Cholera toxin (CT) mutants lacking the A subunit alone or both the A and B subunits were deficient for transcytosis. We explored this finding further and showed that expression of both subunits is required for binding by whole V. cholerae to immobilized CT receptor, the glycosphingolipid GM1. Confocal microscopy showed CT associated with transcytosing bacteria, and transcytosis was inhibited by pre-incubation with GM1 before infection. Finally, heat treatment of the bacterial cells caused a loss of binding to GM1 that was correlated with a significant decrease in uptake and transcytosis by the monolayer. Our data support a model in which the ability of bacteria to interact with GM1 in a CT-dependent fashion plays a critical role in transcytosis of V. cholerae by M cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16681839     DOI: 10.1111/j.1462-5822.2005.00681.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  12 in total

1.  Solid-phase capture of pathogenic bacteria by using gangliosides and detection with real-time PCR.

Authors:  Prerak T Desai; Marie K Walsh; Bart C Weimer
Journal:  Appl Environ Microbiol       Date:  2008-02-08       Impact factor: 4.792

Review 2.  Induction of intestinal lymphoid tissue formation by intrinsic and extrinsic signals.

Authors:  Daniela Finke
Journal:  Semin Immunopathol       Date:  2009-06-09       Impact factor: 9.623

3.  Proteomic analysis of Vibrio cholerae outer membrane vesicles.

Authors:  Emrah Altindis; Yang Fu; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

Review 4.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

5.  Antibodies enhance interaction of Vibrio cholerae with intestinal M-like cells.

Authors:  Luz P Blanco; Victor J Dirita
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

6.  Murine norovirus transcytosis across an in vitro polarized murine intestinal epithelial monolayer is mediated by M-like cells.

Authors:  Mariam B Gonzalez-Hernandez; Thomas Liu; Luz P Blanco; Heather Auble; Hilary C Payne; Christiane E Wobus
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

7.  Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers.

Authors:  Carol L Roberts; Asa V Keita; Sylvia H Duncan; Niamh O'Kennedy; Johan D Söderholm; Jonathan M Rhodes; Barry J Campbell
Journal:  Gut       Date:  2010-09-02       Impact factor: 23.059

8.  Campylobacter jejuni induces transcytosis of commensal bacteria across the intestinal epithelium through M-like cells.

Authors:  Lisa D Kalischuk; Frances Leggett; G Douglas Inglis
Journal:  Gut Pathog       Date:  2010-11-01       Impact factor: 4.181

9.  Establishment and Evaluation of an in vitro M Cell Model using C2BBe1 Cells and Raji Cells.

Authors:  Kazuya Masuda; Akinobu Kajikawa; Shizunobu Igimi
Journal:  Biosci Microflora       Date:  2011-05-26

Review 10.  Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli.

Authors:  Ali Shawki; Declan F McCole
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.